ResearcherUniversity of LiègeActive in the last 2 years
Gilles Rademaker
Matched on ORCID iD 0000-0003-0170-781X; OpenAlex author ID A5044858915. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 3 papers · 2026: 2 papers
Papers 11
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. Co-author DOI 10.1016/j.molcel.2026.05.005↗
- Myoferlin at the crossroad of vesicle trafficking and mitochondrial function: implications for pancreatic cancer progression and stromal reprogramming. Co-author DOI 10.1042/bst20260427↗
- PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Co-author DOI 10.1038/s41586-025-09017-8↗
- Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. Co-author DOI 10.1038/s41598-025-27134-2↗
- Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. Co-author DOI 10.1038/s44318-025-00570-6↗
- Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.redox.2022.102324↗
- Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-22-0044↗
- Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. Co-author DOI 10.1038/s41556-021-00644-7↗
- Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. First author DOI 10.1002/ijc.32247↗
- Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity through the Control of Oxidative Phosphoryla… Co-author DOI 10.3390/cancers11060853↗
- Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Co-author DOI 10.1038/s41388-018-0287-z↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akeila Bellahcène · 7 shared papers, 2018–2026 · strength 1.17
- Paper Myoferlin at the crossroad of vesicle trafficking and mitochondrial function: implications for pancreatic cancer progre… DOI 10.1042/bst20260427↗
- Paper Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. DOI 10.1038/s41598-025-27134-2↗
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Olivier Peulen · 7 shared papers, 2018–2026 · strength 1.17
- Paper Myoferlin at the crossroad of vesicle trafficking and mitochondrial function: implications for pancreatic cancer progre… DOI 10.1042/bst20260427↗
- Paper Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. DOI 10.1038/s41598-025-27134-2↗
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Raphaël Peiffer · 5 shared papers, 2018–2026 · strength 0.99
- Paper Myoferlin at the crossroad of vesicle trafficking and mitochondrial function: implications for pancreatic cancer progre… DOI 10.1042/bst20260427↗
- Paper Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. DOI 10.1038/s41598-025-27134-2↗
- Paper Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. DOI 10.1038/s44318-025-00570-6↗
- Rushika Miriam Perera · 4 shared papers, 2021–2026 · strength 0.67
- Paper A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. DOI 10.1016/j.molcel.2026.05.005↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in … DOI 10.1158/2159-8290.cd-22-0044↗
- Charlotte Gullo · 2 shared papers, 2025 · strength 0.44
- Anthony C. Venida · 2 shared papers, 2022–2026 · strength 0.37
- Paper A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer. DOI 10.1016/j.molcel.2026.05.005↗
- Paper Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in … DOI 10.1158/2159-8290.cd-22-0044↗
- Roberto Zoncu · 2 shared papers, 2021–2025 · strength 0.30
- Grace Kim · 2 shared papers, 2021–2025 · strength 0.30
- Vincent Castronovo · 3 shared papers, 2018–2022 · strength 0.28
- Paper Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2022.102324↗
- Paper Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes … DOI 10.1002/ijc.32247↗
- Paper Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressi… DOI 10.1038/s41388-018-0287-z↗
- Marine Berquez · 1 shared paper, 2026 · strength 0.26
- Brunella Costanza · 3 shared papers, 2018–2019 · strength 0.24
- Paper Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity thro… DOI 10.3390/cancers11060853↗
- Paper Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes … DOI 10.1002/ijc.32247↗
- Paper Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressi… DOI 10.1038/s41388-018-0287-z↗
- Sandy Anania · 2 shared papers, 2019–2022 · strength 0.22
- Rebekah Crake · 1 shared paper, 2025 · strength 0.21
- Atsushi Masamune · 1 shared paper, 2025 · strength 0.21
- Michael Guenther · 1 shared paper, 2025 · strength 0.18
- Michael Haas · 1 shared paper, 2025 · strength 0.18
- Steffen Ormanns · 1 shared paper, 2025 · strength 0.18
- Stephan Krüger · 1 shared paper, 2025 · strength 0.18
- Lisa Miller‐Phillips · 1 shared paper, 2025 · strength 0.18
- Volker Heinemann · 1 shared paper, 2025 · strength 0.18
- Eric Andrew Collisson · 1 shared paper, 2025 · strength 0.18
- Jen Jen Yeh · 1 shared paper, 2025 · strength 0.18
- Stefan Hubert Boeck · 1 shared paper, 2025 · strength 0.18
- Gina M. DeNicola · 1 shared paper, 2022 · strength 0.12
- Mirunalini Ravichandran · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.